Ausgewählte Publikationen AG Mahotka
| Publikationen von PD Dr. rer. nat. Csaba Mahotka via PubMed |  |
| Edgar Grinstein, Csaba Mahotka Single-cell transcriptome profiling of human HSCs during development: new insights into HSC ontogeny Signal Transduct Target Ther. 2023 Feb 6;8(1):59. doi: 10.1038/s41392-022-01301-7. | |
| Sven Reister, Csaba Mahotka, Edgar Grinstein Nucleolin as activator of TCF7L2 in human hematopoietic stem/progenitor cells Leukemia. 2021 Dec;35(12):3616-3618. doi: 10.1038/s41375-021-01434-8. Epub 2021 Nov 19. | |
| Sven Reister, Csaba Mahotka, Natascha van den Höfel, Edgar Grinstein Nucleolin promotes Wnt signaling in human hematopoietic stem/progenitor cells Leukemia. 2019 Apr;33(4):1052-1054. doi: 10.1038/s41375-019-0401-4. Epub 2019 Feb 22. | |
| Csaba Mahotka, Sanil Bhatia, Jutta Kollet, Edgar Grinstein Nucleolin promotes execution of the hematopoietic stem cell gene expression program Leukemia. 2018 Aug;32(8):1865-1868. doi: 10.1038/s41375-018-0090-4. Epub 2018 Mar 8. | |
| Wethkamp N, Hanenberg H, Funke S, Suschek CV, Wetzel W, Heikaus S, Grinstein E, Ramp U, Engers R, Gabbert HE, Mahotka C. Daxx-beta and Daxx-gamma, two novel splice variants of the transcriptional co-repressor Daxx J Biol Chem. 2011 Jun 3;286(22):19576-88. doi: 10.1074/jbc.M110.196311. Epub 2011 Apr 10. PubMed PMID: 21482821 | |
| Krieg A, Schulte am Esch J 2nd, Ramp U, Hosch SB, Knoefel WT, Gabbert HE, Mahotka C. TRAIL-R4-beta: a new splice variant of TRAIL-receptor 4 lacking the cysteine rich domain 1 Biochem Biophys Res Commun. 2006 Oct 13;349(1):115-21. Epub 2006 Aug 14. PubMed PMID: 16934748. | |
| Wethkamp N, Ramp U, Geddert H, Schulz WA, Florl AR, Suschek CV, Hassan M, Gabbert HE, Mahotka C. Expression of death-associated protein kinase during tumour progression of human renal cell carcinomas: hypermethylation-independent mechanisms of inactivation Eur J Cancer. 2006 Jan;42(2):264-74. Epub 2006 Jan 4. PubMed PMID: 16386893. | |
| Yan* Y, Mahotka* C, Heikaus S, Shibata T, Wethkamp N, Liebmann J, Suschek CV, Guo Y, Gabbert HE, Gerharz CD, Ramp U. Disturbed balance of expression between XIAP and Smac/DIABLO during tumour progression in renal cell carcinomas Br J Cancer. 2004 Oct 4;91(7):1349-57. PubMed PMID: 15328523; * = equal authorship | |
| Krieg A, Krieg T, Wenzel M, Schmitt M, Ramp U, Fang B, Gabbert HE, Gerharz CD, Mahotka C. TRAIL-beta and TRAIL-gamma: two novel splice variants of the human TNF-related apoptosis-inducing ligand (TRAIL) without apoptotic potential Br J Cancer. 2003 Mar 24;88(6):918-27. PubMed PMID: 12644830. | |
| Mahotka C, Liebmann J, Wenzel M, Suschek CV, Schmitt M, Gabbert HE, Gerharz CD. Differential subcellular localization of functionally divergent survivin splice variants Cell Death Differ. 2002 Dec;9(12):1334-42. PubMed PMID: 12478470. | |
| Mahotka C, Krieg T, Krieg A, Wenzel M, Suschek CV, Heydthausen M, Gabbert HE, Gerharz CD. Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas Int J Cancer. 2002 Jul 1;100(1):30-6. PubMed PMID: 12115583. | |
| Wenzel M, Mahotka C, Krieg A, Bachmann A, Schmitt M, Gabbert HE, Gerharz CD. Novel survivin-related members of the inhibitor of apoptosis (IAP) family Cell Death Differ. 2000 Jul;7(7):682-3. PubMed PMID: 11023343. | |
| Mahotka C, Wenzel M, Springer E, Gabbert HE, Gerharz CD. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties Cancer Res. 1999 Dec 15;59(24):6097-102. PubMed PMID: 10626797. | |
| Mahotka C, Hansen-Hagge TE, Bartram CR. Alternative splicing of T cell receptor (TCR) alpha chain transcripts containing V alpha 1 or V alpha 14 elements Leukemia. 1995 Oct;9(10):1700-3. PubMed PMID: 7564513. | |